News & Articles
Selected Filters:
Horizon Discovery Takes Exclusive License for Novel Transposon-Based Gene Editing Technology Platform
New technology has immediate applications in biomanufacturing, diagnostics, cell and gene therapy
Free Webinar – Life Sciences Applications in UV/Vis Spectroscopy
Learn how to use your UV/Vis spectrophotometer in different life sciences applications
T Cell Engineering for Breakthrough Immunotherapy Research
Discover the world’s only fully automated, GMP-compliant, CAR T cell manufacturing system
SCIENION Announces Itinerary for Workshop Series, Berlin 2017
Experts from across the globe expected to descend on German capital for two-day workshop series, September 7-8
llumina Announces FDA-approved Next-Generation Sequencing Cancer Companion Diagnostic Test Kit
Extended RAS Panel helps identify colorectal cancer patients eligible for Amgen’s Vectibix
New Olympus CX3 Series Upright Microscopes
Olympus CX3 series upright microscopes enable error-free microscopy for users of all levels and experience
Repurposing Existing Drugs to Speed Up the Development of Therapies for Rare Muscular Dystrophies
Discover how a research group at the University of Geneva, Switzerland, is using an innovative approach to accelerate therapeutics through the drug development process
Bioconjugation Specialist Innova Biosciences Acquired by SYGNIS AG
Innova CEO and CSO Dr. Nick Gee becomes Chief Technical Officer of SYGNIS
Horizon Reference Standards Used in FDA Approval of New Oncology Companion Diagnostic Test
Horizon’s reference standards supported assay development and subsequent clinical trial
Optimizing Clinical LC-MS/MS Workflow at The University-Hospital Padova
Find out how this busy laboratory in Italy has adapted to meet increased demand for clinical mass spectrometry testing
Study Confirms that InSphero Human Liver Microtissue is Better at Predicting Drug-induced Liver Injury
Archives of Toxicology publication reveals microtissues are twice as sensitive as 2D primary human hepatocytes (PHH) for predicting hepatotoxicity of 110 clinically defined DILI compounds.
Abcam plc Exercises Exclusivity Provision of License and Supply Agreement with Horizon Discovery
Abcam extends a pre-existing license and supply agreement with Horizon by exercising an exclusivity provision for the period from July 2017 through June 2018
Gyros Protein Technologies Introduces New ADA Solution for Immunogenicity Market
Developed to support assay development and validation for detection of anti-drug antibodies
NEW SelectScience® Seals of Quality Help Scientists Select the Best Lab Products
Top rated products now visible at a glance as first Seal of Quality recipients revealed
Webinar Highlights: Avoiding "Poor" Pore Selection
Read the Q&A highlights of our recent webinar on the importance of column pore and particle architecture for biomacromolecule UHPLC separations























